Top News: Galena Biopharma Inc (NASDAQ:GALE), TubeMogul, Inc. (NASDAQ:TUBE), Nokia Corporation (ADR) (NYSE:NOK), Insmed Incorporated (NASDAQ:INSM),

Galena Biopharma Inc (NASDAQ:GALE) announced that the Company will report its fourth quarter and year end 2015 financial results and provide a corporate update on Thursday, March 10, 2016, after the close of the financial markets. The company will host a conference call folllowing the announcement at 2:00 p.m. P.T./5:00 pm E.T. to discuss the financial and business results.

Galena Biopharma Inc (NASDAQ:GALE) belongs to Healthcare sector. Its weekly performance is -2.98%. On last trading day company shares ended up at $0.81. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is -23.30%.

TubeMogul, Inc. (NASDAQ:TUBE) announced a bold new anti-ad fraud effort on Monday. The company is promising to issue automatic refunds to any advertiser whose ads were served to non-human traffic, also known as bots.

TubeMogul, Inc. (NASDAQ:TUBE) shares fell -2.18% in last trading session and ended the day at $12.56. TUBE Gross Margin is 68.90% and its return on assets is -9.10%. TubeMogul, Inc. (NASDAQ:TUBE) quarterly performance is 2.70%.

On 24 February, Nokia Corporation (ADR) (NYSE:NOK) said that, it’s the first to run 5G on a commercially available base station. That’s a significant claim not only because the 5G standards have not yet been written, but for operators like Verizon (NYSE: VZ), it means they can launch pre-5G sooner rather than later.

Nokia Corporation (ADR) (NYSE:NOK) belongs to Technology sector. Its net profit margin is 21.50% and weekly performance is 0.99%. On last trading day company shares ended up at $6.14. Nokia Corporation (ADR) (NYSE:NOK) distance from 50-day simple moving average (SMA50) is -8.73%.

Insmed Incorporated (NASDAQ:INSM) had its target price lowered by analysts at Leerink Swann from $29.00 to $23.00 in a note issued to investors on Friday, MarketBeat reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Leerink Swann’s target price points to a potential upside of 88.06% from the company’s previous close.

Insmed Incorporated (NASDAQ:INSM) ended the last trading day at $11.80. Company weekly volatility is calculated as 8.73% and price to cash ratio as 2.58. Insmed Incorporated (NASDAQ:INSM) showed a weekly performance of -5.75%.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) reported financial results for the fourth quarter and year ended December 31, 2015, along with a general business update. The $20.4 million net loss attributable to common stockholders for the fourth quarter of 2015 includes $20.0 million in operating expenses, reflecting $12.3 million in research and development expenses and $7.6 million in general and administrative expenses.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) shares fell -0.48% in last trading session and ended the day at $16.76. AERI return on assets is -39.80%. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) quarterly performance is -38.54%.

Leave a Reply

Your email address will not be published. Required fields are marked *